Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04788043 |
|---|---|
| Brief Title: | Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma |
| First Submitted : | March 4, 2021 |
| First Submitted that Met QC Criteria : | March 4, 2021 |
| First Posted : | March 9, 2021 |
| Last Update Submitted that Met QC Criteria : | February 20, 2024 |
| Last Update Posted : | February 21, 2024 |